BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 19, 2004
View Archived Issues
NPS Pharmaceuticals reviews progress of late-stage product candidates
Read More
Fazaclo receives FDA approval
Read More
AEterna expands pipeline through Zentaris research collaborations
Read More
Neuroprotective effects of SUN-N8075 shown in animal models of stroke
Read More
Antiplatelet and neuroprotective effects of FK-419 shown in vitro and in vivo
Read More
Antares' topical oxybutynin product successfully completes phase I trial
Read More
Launch of new Salagen dosage
Read More
Serono gains access to ProMetic's protein purification technology
Read More
Clinical evidence of the efficacy of Caduet in hypertension and high cholesterol
Read More
Promising effects found with ABT-578-eluting stents in de novo coronary lesions
Read More
An oral insulin spray enhances the postprandial efficacy of oral hypoglycemic drugs
Read More
SOM-230 reported effective in reducing serum GH levels of acromegalic patients
Read More
Efficacy and safety of tacrolimus in rheumatoid arthritis unresponsive to DMARDs
Read More
New MMP/TACE inhibitors in early development at BMS
Read More
BMS scientists design novel beta-secretase inhibitors
Read More
New cannabinoid CB1 antagonists and their use as antiobesity agents
Read More
Two novel series of sodium channel blockers and their use in pain, neuronal ischemia, etc.
Read More
Novel antiangiogenic tyrosine kinase inhibitor claimed by Boehringer Ingelheim
Read More
Merck patent covers new cannabinoid CB1 inhibitors and their use
Read More
Encouraging preclinical results with novel anti-anthrax antibody
Read More
Targeting beta-amyloid aggregation for Alzheimer therapy
Read More
Hart-Scott-Rodino wait over for Neurocrine purchase of indiplon rights
Read More
Maxim reacquires rights to MX-2105 series
Read More
Atrix signs feasibility agreement for development of Aventis compounds
Read More
European orphan drug status for AMT's LPL gene therapy product
Read More
Corgenix Medical and Genesis Bioventures sign merger agreement
Read More
MLN-2704 selected for CMA Pilot 2 Program
Read More
tgAAC94 enters phase I rheumatoid arthritis study
Read More